12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lyrica pregabalin regulatory update

The American Academy of Neurology (AAN) issued a new guideline recommending Pfizer's Lyrica pregabalin to treat diabetic neuropathic pain. The guidelines stated that the GABA receptor agonist is established as...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >